Characterisation and Prognostic Implication of Cholestasis After Burn Injury
- PMID: 41532300
- DOI: 10.1111/apt.70505
Characterisation and Prognostic Implication of Cholestasis After Burn Injury
Abstract
Background: Cholestasis is a frequent phenomenon in patients with burn injury and linked with impaired outcomes.
Aims: To explore longitudinal trajectories of cholestasis and validate the proposed definition of burn-associated cholestasis (BAC).
Methods: 532 patients admitted to an intensive care unit (ICU) for burn injury over a 10-year timeframe were included in this single-center, retrospective cohort study. Burn severity, ICU treatment, and laboratory parameters were longitudinally collected from admission to discharge or death.
Results: Median total body surface area burned was 15% and 234 patients (44%) had severe burn (≥ 20%). 118 patients (22%) met the proposed criteria of BAC while 41%, 30%, and 68% developed elevated alkaline phosphatase, bilirubin, and gamma-glutamyl transferase, respectively. BAC was associated with burn severity, ketamine use, mechanical ventilation, and parenteral nutrition, and 85% of cases occurred in patients exposed to ketamine, mechanical ventilation, and parenteral nutrition. Hyperbilirubinemia (≥ 2× upper-limit-of-normal, i.e., BAC subtype B/C) was independently associated with mortality adjusting for burn severity, critical illness severity, and ICU-specific treatment. However, bilirubin alone provided better discrimination, especially regarding excess deaths after ≥ 7 days (Harrel's C: 0.80-0.83). Concordant increases in bilirubin and alkaline phosphatase/gamma-glutamyl transferase allow for early identification of an at-risk population. Developing hyperbilirubinemia until Day 14 identified a subgroup with severely impaired prognosis (survival at 90 days: 46% vs. 95%).
Conclusions: Cholestasis is frequent following burn injury. Prognosis is determined by bilirubin dynamics independently of disease and burn severity. Hyperbilirubinemia is associated with excess mortality ≥ 7 days after surviving burn injury.
Keywords: BAC; bilirubin; burn‐associated cholestasis; critical illness; intensive care; ketamine; severe burn.
© 2025 The Author(s). Alimentary Pharmacology & Therapeutics published by John Wiley & Sons Ltd.
References
-
- M. G. Jeschke, M. E. van Baar, M. A. Choudhry, K. K. Chung, N. S. Gibran, and S. Logsetty, “Burn Injury,” Nature Reviews. Disease Primers 6, no. 1 (2020): 11.
-
- C. Tapking, K. Kilian, G. Hundeshagen, et al., “Hepatic Functional Pathophysiology and Morphological Damage Following Severe Burns: A Systematic Review and Meta‐Analysis,” Journal of Burn Care & Research 43, no. 5 (2022): 1074–1080.
-
- G. P. Dobson, J. L. Morris, and H. L. Letson, “Pathophysiology of Severe Burn Injuries: New Therapeutic Opportunities From a Systems Perspective,” Journal of Burn Care & Research 45, no. 4 (2024): 1041–1050.
-
- M. G. Jeschke, “The Hepatic Response to Thermal Injury: Is the Liver Important for Postburn Outcomes?,” Molecular Medicine 15, no. 9–10 (2009): 337–351.
-
- C. de Tymowski, F. Dépret, S. Soussi, et al., “Contributing Factors and Outcomes of Burn‐Associated Cholestasis,” Journal of Hepatology 71, no. 3 (2019): 563–572.
LinkOut - more resources
Full Text Sources
Miscellaneous
